|
|
|
|
| LEADER |
02674nam a22003495i 4500 |
| 001 |
000277530 |
| 005 |
20210319113707.0 |
| 007 |
cr nn 008mamaa |
| 008 |
140822s2014 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781493912278
|
| 024 |
7 |
|
|a 10.1007/978-1-4939-1227-8
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Cardiac Energy Metabolism in Health and Disease /
|c edited by Gary D. Lopaschuk, Naranjan S. Dhalla.
|
| 250 |
|
|
|a 1st ed. 2014.
|
| 260 |
# |
# |
|a New York, NY :
|b Springer New York :
|b Imprint: Springer,
|c 2014.
|
| 300 |
|
|
|a XV, 295 p. 54 illus., 25 illus. in color. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Advances in Biochemistry in Health and Disease ;
|v 11
|
| 505 |
0 |
|
|a Part 1. Control of Energy Metabolism -- 1. A Primer on Carbohydrate Metabolism in the Heart -- 2. Lipoproteins: A Source of Cardiac Lipids -- 3. Role of Lipoprotein Lipase in Fatty Acid Delivery to the Heart -- 4. Control of Myocardial Fatty Acid Uptake -- 5. Cardiac Energy Metabolism in Heart Failure Associated with Obesity and Diabetes -- 6. Transcriptional Control of Mitochondrial Biogenesis and Maturation -- 7. Relationship between Substrate Metabolism and Cardiac Efficiency -- 8. Acetylation in the Control of Mitochondrial Metabolism and Integrity -- Part 2. Alteration in Energy Metabolism -- 9. Adrenergic Control of Cardiac Fatty Acid Oxidation in Diabetes -- 10. The Myocardial Creatine Kinase System in the Normal, Ischaemic and Failing Heart -- 11. Fuel Metabolism Plasticity in Pathological Cardiac Hypertrophy and Failure -- 12. Defects in Mitochondrial Oxidative Phosphorylation in Hearts Subjected to Ischemia-Reperfusion Injury -- 13. The Role of AMPK in the Control of Cardiac Hypertrophy -- 14. The Role of Incomplete Fatty Acid Oxidation in the Development of Cardiac Insulin Resistance -- Part 3. Optimization of Energy Metabolism -- 15. Metabolic Therapy for the Ischemic Heart -- 16. Inhibition of Fatty Acid Oxidation to Treat Heart Failure in Patients -- 17. Cardiac Metabolic Protection for the Newborn Heart -- 18. Targeting Transcriptional Control of Fatty Acid Oxidation to Treat Heart Disease.
|
| 650 |
|
0 |
|a Biochemistry.
|
| 650 |
|
0 |
|a Metabolism.
|
| 650 |
|
0 |
|a Cardiology.
|
| 650 |
1 |
4 |
|a Biochemistry, general.
|
| 650 |
2 |
4 |
|a Metabolomics.
|
| 650 |
2 |
4 |
|a Cardiology.
|
| 700 |
1 |
|
|a Lopaschuk, Gary D.
|e editor.
|
| 700 |
1 |
|
|a Dhalla, Naranjan S.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 900 |
|
|
|a Libro descargado a ALEPH en bloque (proveniente de proveedor)
|